ClinicalTrials.Veeva

Menu

Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)

M

Mingzhao Xiao

Status

Enrolling

Conditions

Recurrent Renal Cell Cancer
Clear Cell Renal Cell Carcinoma
Prognostic Cancer Model

Study type

Observational

Funder types

Other

Identifiers

NCT06088134
DL-ccRCC

Details and patient eligibility

About

This study aims to preoperatively predict DFS of patients with localised ccRCC using a deep learning prognostic model based on enhanced contrast CT images, validate it's predictive ability in multicentre data and compare it's predictive ability with traditional models.

Enrollment

800 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • underwent partial/radical nephrectomies
  • histologically diagnosed as ccRCC
  • with complete clinical data and preoperative CT image data

Exclusion criteria

  • with incomplete clinic-pathological data
  • lack of preoperative contrast-enhanced CT images or the image quality was unsuitable for analysis
  • who received pre-surgery neoadjuvant or adjuvant therapies
  • with multiple renal tumors or/and had synchronous metastasis

Trial design

800 participants in 2 patient groups

Non-recurrence group
Recurrence group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems